CADAP 6 supports the drug demand aspect of a balanced drug policy in line with the EU Drug Strategy 2013-2020 and the EU Central Asia Drug Action Plan 2014-2020 and assists the Central Asian governments in strengthening the capacity of national agencies to deal with the drug phenomenon in a comprehensive, integrative, and sustainable manner.

All programme activities under CADAP 6 focus both on national and regional capacity building by providing policy advice and technical assistance, monitoring of the drugs situation, prevention, drug treatment and harm reduction services. CADAP 6 budget amounted over EUR 6.5 MLN from the European Union.